• Disseminating quality mental metrics to clinical research maximizes the rate of success and minimizes the time-to-market of new drugs that enter clinical drug development programmes.

• Mental measures of high quality enhance the reliability and validity of proof of concept studies and thus they advance the accuracy of critical go-nogo decisions.

• Purchasing in-depth psychometric intelligence is the best way to make smarter business decisions that reduce costs.

• Take advantage of a scientific staff with combined clinical experience and formal training in advanced psychometric techniques.